Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activity-Based Detection of Cannabinoids in Serum and Plasma Samples
Annelies Cannaert, Jolien Storme, Cornelius Heß, et al.
Clinical Chemistry (2018) Vol. 64, Iss. 6, pp. 918-926
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96
Screening methods for rapid determination of new psychoactive substances (NPS) in conventional and non-conventional biological matrices
Silvia Graziano, Luca Anzillotti, Giulio Mannocchi, et al.
Journal of Pharmaceutical and Biomedical Analysis (2018) Vol. 163, pp. 170-179
Closed Access | Times Cited: 85
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Elise Wouters, Jolien Walraed, Samuel D. Banister, et al.
Biochemical Pharmacology (2019) Vol. 169, pp. 113623-113623
Closed Access | Times Cited: 79
Application of an activity‐based receptor bioassay to investigate the in vitro activity of selected indole‐ and indazole‐3‐carboxamide‐based synthetic cannabinoids at CB1 and CB2 receptors
Carolina Noble, Annelies Cannaert, Kristían Línnet, et al.
Drug Testing and Analysis (2018) Vol. 11, Iss. 3, pp. 501-511
Closed Access | Times Cited: 71
Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples
Lysbeth H. Antonides, Annelies Cannaert, Caitlyn Norman, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 63
Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds
Elise Wouters, Jolien Walraed, Michael J. Robertson, et al.
ACS Pharmacology & Translational Science (2019) Vol. 3, Iss. 2, pp. 285-295
Open Access | Times Cited: 56
Cannabinoid receptor activation potential of the next generation, generic ban evading OXIZID synthetic cannabinoid receptor agonists
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1565-1575
Open Access | Times Cited: 30
Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids
Annelies Cannaert, Lakshmi Vasudevan, Melissa Friscia, et al.
Clinical Chemistry (2018) Vol. 64, Iss. 8, pp. 1221-1229
Open Access | Times Cited: 51
Functional evaluation of carboxy metabolites of synthetic cannabinoid receptor agonists featuring scaffolds based on L‐valine or L‐tert‐leucine
Elise Wouters, Lukas Mogler, Annelies Cannaert, et al.
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1183-1191
Open Access | Times Cited: 43
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
Philipp Spatz, Sophie A. M. Steinmüller, Anna Tutov, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6414-6435
Open Access | Times Cited: 14
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays—Part II: Structure activity relationship assessment via a β‐arrestin recruitment assay
Katharina Elisabeth Grafinger, Annelies Cannaert, Adam Ametovski, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 7, pp. 1402-1411
Closed Access | Times Cited: 32
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
Iu Raïch, Rafael Rivas‐Santisteban, Alejandro Lillo, et al.
Pharmacological Research (2021) Vol. 174, pp. 105970-105970
Open Access | Times Cited: 30
A new cannabinoid receptor 1 selective agonist evading the 2021 “China ban”: ADB‐FUBIATA
Marie H. Deventer, Katleen Van Uytfanghe, Inge M. J. Vinckier, et al.
Drug Testing and Analysis (2022) Vol. 14, Iss. 9, pp. 1639-1644
Open Access | Times Cited: 20
Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo‐Pyridyl Synthetic Cannabinoid Receptor Agonist CH‐FUBBMPDORA
Marie H. Deventer, Maria Carmela Emanuele, Bernadette V. Stang, et al.
Drug Testing and Analysis (2025)
Open Access
Simultaneous enrichment and ultra-high sensitivity detection of multi-structural synthetic cannabinoids in large-volume wastewater
Rui Cao, Jiawei Chen, Ningjia Pang, et al.
Microchimica Acta (2025) Vol. 192, Iss. 5
Closed Access
Current state-of-the-art approaches for mass spectrometry in clinical toxicology: an overview
Frank T. Peters, Daniela Wissenbach
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 8, pp. 487-500
Closed Access | Times Cited: 10
In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs
Marie H. Deventer, Mattias Persson, Caitlyn Norman, et al.
Drug Testing and Analysis (2023) Vol. 16, Iss. 6, pp. 616-628
Closed Access | Times Cited: 9
Structure–activity relationships of valine, tert-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin, et al.
RSC Medicinal Chemistry (2021) Vol. 13, Iss. 2, pp. 156-174
Open Access | Times Cited: 19
Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) “Cis-On” Agonist
Diego A. Rodríguez‐Soacha, Sophie A. M. Steinmüller, Ali Işbilir, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 16, pp. 2410-2435
Open Access | Times Cited: 12
Activity-based detection of synthetic cannabinoid receptor agonists in plant materials
A. J. Timmerman, Margot Balcaen, Vera Coopman, et al.
Harm Reduction Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Activity-based reporter assays for the screening of abused substances in biological matrices
Annelies Cannaert, Marthe M. Vandeputte, Sarah M.R. Wille, et al.
Critical Reviews in Toxicology (2019) Vol. 49, Iss. 2, pp. 95-109
Closed Access | Times Cited: 19
In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB‐CHMINACA via human liver microsome incubation and high‐resolution mass spectrometry
Brandon C. Presley, Barry K. Logan, Susan A. Jansen‐Varnum
Drug Testing and Analysis (2019) Vol. 11, Iss. 8, pp. 1264-1276
Closed Access | Times Cited: 16
Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances
Eline Pottie, Annelies Cannaert, Katleen Van Uytfanghe, et al.
Analytical Chemistry (2019) Vol. 91, Iss. 24, pp. 15444-15452
Closed Access | Times Cited: 16
The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?
Sarah M.R. Wille, Simon Elliott
Journal of Analytical Toxicology (2020) Vol. 45, Iss. 7, pp. 619-632
Open Access | Times Cited: 15
Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum Samples
Liesl K. Janssens, Dimitri Boeckaerts, Simon Hudson, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 7, pp. 906-916
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top